Early antibody treatment, inflammation, and risk of post-COVID conditions, 2023, Gebo et al.
Discussion in 'Long Covid research' started by SNT Gatchaman, Sep 20, 2023.
Tags:
Discussion in 'Long Covid research' started by SNT Gatchaman, Sep 20, 2023.